Three writers. One standard.
Three beats, split the way the decisions actually split: which provider is worth ordering from, what the trials show, and what it actually costs. Each writer owns one of them.
We attach no degrees, no institutional affiliations and no clinical credentials to our writers, because we do not have any to attach and inventing them is the oldest trick in this category. What is real is the sourcing: every figure, dose and claim traces to the trial, the label or the paper of record, checked against the database before it published. Judge the citations.
Beats are stable on purpose. The same name always covers the same ground, so if you disagree with how this site ranks a provider, you know exactly whose reasoning to argue with.
Hana Brennan
Pricing & provider dataWhat a GLP-1 actually costs per month, once the advertised figure stops applying.
View profile →Owen Castellanos
Evidence & trialsWhat the GLP-1 trials actually measured, and where the compounded market departs from them.
View profile →Tessa Whitfield
EditorCorrections, methodology, and what this site will not publish.
View profile →How we research and where we draw the line is set out in our methodology and editorial policy.